Free Trial

Haleon (HLN) Stock Price, News & Analysis

-0.04 (-0.48%)
(As of 05/29/2024 ET)
Today's Range
50-Day Range
52-Week Range
4.01 million shs
Average Volume
5.76 million shs
Market Capitalization
$38.13 billion
P/E Ratio
Dividend Yield
Price Target

Haleon MarketRank™ Stock Analysis

Analyst Rating
Short Interest
0.42% of Float Sold Short
Dividend Strength
Based on Four Factors
News Sentiment
0.57mentions of Haleon in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth
From $0.46 to $0.51 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.78 out of 5 stars

Medical Sector

434th out of 932 stocks

Toilet Preparations Industry

8th out of 13 stocks

HLN stock logo

About Haleon Stock (NYSE:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

HLN Stock News Headlines

Sales Call
Haleon shares slide as revenue declines
Stocks Making Big Moves Today
Pfizer Plans To Sell About 630 Mln Haleon Shares
Haleon plc (HLN) Q4 2023 Earnings Call Transcript
See More Headlines
Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/16 Dividend
Last Earnings
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Toilet preparations
Year Founded


Net Income
$1.30 billion
Pretax Margin


Sales & Book Value

Annual Sales
$14.05 billion
Cash Flow
$0.36 per share
Book Value
$4.51 per share


Outstanding Shares
Free Float
Market Cap
$37.94 billion
Not Optionable
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Brian James McNamara (Age 58)
    CEO & Executive Director
    Comp: $4.32M
  • Mr. Tobias Hannes Hestler (Age 52)
    CFO & Executive Director
    Comp: $2.4M
  • Ms. Sonya Ghobrial (Age 50)
    Head of Investor Relations
  • Ms. Tamara Rogers (Age 54)
    Chief Marketing Officer
  • Mr. Filippo Lanzi
    President of EMEA & LatAm
  • Mr. Keith Choy (Age 55)
    President of Asia Pacific
  • Ms. Lisa Paley (Age 57)
    President of North America
  • Mr. Franck Riot (Age 56)
    Chief R&D Officer
  • Mr. Bjorn Timelin
    Head of Strategy
  • Ms. Namrata P. Patel (Age 58)
    Chief Supply Chain Officer

HLN Stock Analysis - Frequently Asked Questions

Should I buy or sell Haleon stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HLN shares.
View HLN analyst ratings
or view top-rated stocks.

How have HLN shares performed in 2024?

Haleon's stock was trading at $8.23 at the beginning of 2024. Since then, HLN shares have increased by 1.5% and is now trading at $8.35.
View the best growth stocks for 2024 here

Are investors shorting Haleon?

Haleon saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 19,120,000 shares, a decline of 21.5% from the April 30th total of 24,360,000 shares. Based on an average daily volume of 6,900,000 shares, the short-interest ratio is presently 2.8 days. Approximately 0.4% of the shares of the stock are short sold.
View Haleon's Short Interest

When is Haleon's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024.
View our HLN earnings forecast

How were Haleon's earnings last quarter?

Haleon plc (NYSE:HLN) issued its earnings results on Wednesday, May, 1st. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.01. The business had revenue of $3.70 billion for the quarter, compared to analyst estimates of $3.71 billion. Haleon had a trailing twelve-month return on equity of 13.17% and a net margin of 9.68%.

How often does Haleon pay dividends? What is the dividend yield for Haleon?

Haleon declared a semi-annual dividend on Thursday, February 29th. Investors of record on Friday, March 15th will be given a dividend of $0.1064 per share on Thursday, May 16th. This represents a dividend yield of 1.8%. The ex-dividend date of this dividend is Thursday, March 14th.
Read our dividend analysis for HLN

Is Haleon a good dividend stock?

Haleon (NYSE:HLN) pays an annual dividend of $0.21 per share and currently has a dividend yield of 2.51%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 70.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HLN will have a dividend payout ratio of 41.18% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HLN.

What ETFs hold Haleon's stock?
Who are Haleon's major shareholders?

Haleon's stock is owned by a variety of institutional and retail investors. Top institutional investors include Clearbridge Investments LLC (0.84%), Douglas Lane & Associates LLC (0.18%), Martin Investment Management LLC (0.10%), Raymond James & Associates (0.08%), Van ECK Associates Corp (0.07%) and First Eagle Investment Management LLC (0.03%).

How do I buy shares of Haleon?

Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:HLN) was last updated on 5/29/2024 by Staff

From Our Partners